Swiss National Bank Cerevel Therapeutics Holdings, Inc. Transaction History

Swiss National Bank

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$40.88 - $43.27 $143,080 - $151,445	3,500 Added 2.51%	143,200 $6.05 Million
Q4 2023 Feb 06, 2024	BUY	$20.27 - $42.44 $36,486 - $76,392	1,800 Added 1.31%	139,700 $5.92 Million
Q3 2023 Nov 08, 2023	BUY	$20.26 - $31.91 $30,390 - $47,865	1,500 Added 1.1%	137,900 $3.01 Million
Q2 2023 Aug 09, 2023	BUY	$23.9 - $35.38 $33,460 - $49,532	1,400 Added 1.04%	136,400 $4.34 Million
Q1 2023 May 10, 2023	SELL	$22.82 - $35.32 $353,710 - $547,460	-15,500 Reduced 10.3%	135,000 $3.29 Million
Q4 2022 Feb 08, 2023	BUY	$25.35 - $31.96 $248,430 - $313,208	9,800 Added 6.97%	150,500 $4.75 Million
Q3 2022 Nov 09, 2022	BUY	$25.5 - $41.42 $48,450 - $78,698	1,900 Added 1.37%	140,700 $3.98 Million
Q2 2022 Aug 09, 2022	BUY	$20.62 - $37.15 $709,328 - $1.28 Million	34,400 Added 32.95%	138,800 $3.67 Million
Q1 2022 May 09, 2022	BUY	$23.5 - $35.38 $206,800 - $311,344	8,800 Added 9.21%	104,400 $3.66 Million
Q4 2021 Feb 08, 2022	BUY	$29.21 - $44.64 $64,262 - $98,208	2,200 Added 2.36%	95,600 $3.1 Million
Q3 2021 Nov 08, 2021	BUY	$21.26 - $38.85 $495,358 - $905,205	23,300 Added 33.24%	93,400 $2.76 Million
Q2 2021 Aug 06, 2021	BUY	$12.56 - $29.69 $880,456 - $2.08 Million	70,100 New	70,100 $1.8 Million

5.01M

3.3K

Ticker CERE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 155,752,000
Description
Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.